drug launch Archives - Journal for Clinical Studies

Current Edition

Regional News

GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout

With a recent pruritus approval in the books and several more potential launches coming in the next year and a half, Switzerland’s Vifor Pharma is tapping longtime Gl...

13 December 2021 Regional News chief commercial officer | china

Continue Reading →

Regional News

Viatris launched two versions of its interchangeable insulin biosimilar. Why?

It's official: Biocon and Viatris have launched their historic interchangeable insulin biosimilar, Semglee. The drug, which references Sanofi's blockbuster diabetes m...

17 November 2021 Regional News Biocon | biosimilar

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout

Viatris launched two versions of its interchangeable insulin biosimilar. Why?

Journal for Clinical Studies